サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451212

呼吸器診断市場レポート：製品・サービスタイプ別、検査タイプ別、疾患別、エンドユーザー別、地域別、2024-2032

Respiratory Diagnostics Market Report by Product and Service Type, Test Type, Disease, End-User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
呼吸器診断市場レポート：製品・サービスタイプ別、検査タイプ別、疾患別、エンドユーザー別、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の呼吸器診断市場規模は2023年に80億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて6.8%の成長率（CAGR）を示し、2032年までに147億米ドルに達すると予測しています。

呼吸器診断とは、肺の機能および関連プロセスの臨床評価を指します。喘息、慢性閉塞性肺疾患（COPD）、肺がん、気管支炎、肺線維症を検出するための機械的、画像的、分子的診断検査が含まれます。スパイロメトリー、オキシメトリー、経皮的CO2モニタリング、鼻腔吸気圧（SNIP）、胸部X線検査、コンピュータ断層撮影（CT）スキャンなどの検査を行う。場合によっては、睡眠時無呼吸症候群や夜間低換気の有無を診断・評価するために睡眠検査も行われます。

呼吸器疾患の有病率の増加は、市場の成長を促す主な要因の一つです。喫煙者の増加やアルコールの消費、座りがちな生活習慣やストレスの多い日常生活などが、COPDや肺がんなどの重篤な呼吸器疾患の発生率の上昇につながっています。さらに、COPDの診断や外来患者の管理にモノのインターネット（IoT）や人工知能（AI）を活用するなど、呼吸器診断におけるさまざまな技術革新が市場成長に好影響を与えています。また、さまざまな民間病院やヘルスケアセンターにおける呼吸器診断の需要の増加や、質の高いヘルスケア施設を誰もが利用できるようにするための政府と非政府組織（NGO）の両者の取り組みが、呼吸器診断市場を牽引しています。その他の市場開拓要因としては、研究開発（R&D）の強化、老人人口の増加、急速な都市化と工業施設の増加、世界の汚染レベルの上昇などが挙げられます。

本レポートで扱う主な質問

  • 世界の呼吸器診断薬市場はこれまでどのように推移し、今後どのように推移していくのか？
  • 世界の呼吸器診断薬産業における主要地域市場は？
  • COVID-19が世界の呼吸器診断薬業界に与えた影響は？
  • 製品タイプ別、サービスタイプ別の市場内訳は？
  • 検査タイプ別の市場内訳は？
  • 疾患別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 世界の呼吸器診断薬産業のバリューチェーンにおける様々な段階とは？
  • 世界の呼吸器診断薬産業における主な促進要因と課題は？
  • 世界の呼吸器診断薬業界の構造と主要プレイヤーは？
  • 世界の呼吸器診断業界における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 呼吸器診断の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳：製品・サービスタイプ別
  • 市場内訳：検査タイプ別
  • 市場内訳：疾患別
  • 市場内訳：エンドユーザー別
  • 市場内訳：地域別
  • 市場予測

第6章 市場内訳：製品・サービスタイプ別

  • 機器とサービス
    • 市場動向
    • 市場予測
  • アッセイと試薬
    • 市場動向
    • 市場予測
  • サービスとソフトウェア
    • 市場動向
    • 市場予測

第7章 市場内訳：検査タイプ別

  • 機械検査
    • 市場動向
    • 市場予測
  • 閉塞性睡眠時無呼吸（OSA）診断検査
    • 市場動向
    • 市場予測
  • 画像検査
    • 市場動向
    • 市場予測
  • 従来の診断検査
    • 市場動向
    • 市場予測
  • 分子診断検査
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：疾患別

  • 結核
    • 市場動向
    • 市場予測
  • 喘息
    • 市場動向
    • 市場予測
  • 慢性閉塞性肺疾患（COPD）
    • 市場動向
    • 市場予測
  • 肺がん
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 診療所
    • 市場動向
    • 市場予測
  • リファレンス・臨床検査室
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 市場動向
    • 市場予測
  • 欧州
    • 市場動向
    • 市場予測
  • アジア太平洋
    • 市場動向
    • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場予測
  • ラテンアメリカ
    • 市場動向
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Philips Healthcare
    • Abbott Laboratories
    • Biomerieux
    • Becton Dickinson
    • Thermo Fisher Scientific Inc.
    • Alere Inc.
    • Seegene Inc.
    • 3M
    • Bio-Rad Laboratories Inc.
    • SDI Diagnostics
    • COSMED
図表

List of Figures

  • Figure 1: Global: Respiratory Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Respiratory Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Respiratory Diagnostics Market: Breakup by Product and Service Type (in %), 2023
  • Figure 4: Global: Respiratory Diagnostics Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Respiratory Diagnostics Market: Breakup by Disease (in %), 2023
  • Figure 6: Global: Respiratory Diagnostics Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Respiratory Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Respiratory Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Respiratory Diagnostics Industry: SWOT Analysis
  • Figure 10: Global: Respiratory Diagnostics Industry: Value Chain Analysis
  • Figure 11: Global: Respiratory Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Respiratory Diagnostics (Instruments and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Respiratory Diagnostics (Instruments and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Respiratory Diagnostics (Assays and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Respiratory Diagnostics (Assays and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Respiratory Diagnostics (Services and Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Respiratory Diagnostics (Services and Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Respiratory Diagnostics (Mechanical Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Respiratory Diagnostics (Mechanical Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Respiratory Diagnostics (Imaging Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Respiratory Diagnostics (Imaging Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Respiratory Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Respiratory Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Respiratory Diagnostics (Tuberculosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Respiratory Diagnostics (Tuberculosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Respiratory Diagnostics (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Respiratory Diagnostics (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Respiratory Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Respiratory Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Respiratory Diagnostics (Other Disease Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Respiratory Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Respiratory Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Respiratory Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Respiratory Diagnostics (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Respiratory Diagnostics (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Respiratory Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Respiratory Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: North America: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: North America: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Asia Pacific: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Asia Pacific: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Middle East and Africa: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Middle East and Africa: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Latin America: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Latin America: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Respiratory Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Respiratory Diagnostics Market Forecast: Breakup by Product and Service Type (in Million US$), 2024-2032
  • Table 3: Global: Respiratory Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 4: Global: Respiratory Diagnostics Market Forecast: Breakup by Disease (in Million US$), 2024-2032
  • Table 5: Global: Respiratory Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Respiratory Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Respiratory Diagnostics Market Structure
  • Table 8: Global: Respiratory Diagnostics Market: Key Players
目次
Product Code: SR112024A1620

The global respiratory diagnostics market size reached US$ 8.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032.

Respiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.

The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth. Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory diagnostics market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product and service type, test type, disease and end-user.

Breakup by Product and Service Type:

Instruments and Services

Assays and Reagents

Services and Software

Breakup by Test Type:

Mechanical Tests

Obstructive Sleep Apnoea (OSA) Diagnostic Tests

Imaging Tests

Traditional Diagnostic Tests

Molecular Diagnostic Tests

Others

Breakup by Disease:

Tuberculosis

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Lung Cancer

Others

Breakup by End-User:

Hospitals

Clinics

Reference and Clinical Laboratories

Others

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics and COSMED.

Key Questions Answered in This Report:

  • How has the global respiratory diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global respiratory diagnostics industry?
  • What has been the impact of COVID-19 on the global respiratory diagnostics industry?
  • What is the breakup of the market based on the product and service type?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the disease?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global respiratory diagnostics industry?
  • What are the key driving factors and challenges in the global respiratory diagnostics industry?
  • What is the structure of the global respiratory diagnostics industry and who are the key players?
  • What is the degree of competition in the global respiratory diagnostics industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Respiratory Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product and Service Type
  • 5.5 Market Breakup by Test Type
  • 5.6 Market Breakup by Disease
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product and Service Type

  • 6.1 Instruments and Services
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Assays and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services and Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Mechanical Tests
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Imaging Tests
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Traditional Diagnostic Tests
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Molecular Diagnostic Tests
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Tuberculosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Asthma
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chronic Obstructive Pulmonary Disease (COPD)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Lung Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Reference and Clinical Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Philips Healthcare
    • 14.3.2 Abbott Laboratories
    • 14.3.3 Biomerieux
    • 14.3.4 Becton Dickinson
    • 14.3.5 Thermo Fisher Scientific Inc.
    • 14.3.6 Alere Inc.
    • 14.3.7 Seegene Inc.
    • 14.3.8 3M
    • 14.3.9 Bio-Rad Laboratories Inc.
    • 14.3.10 SDI Diagnostics
    • 14.3.11 COSMED